CRO

The CRO (Contract Research Organization) theme includes providers of outsourced R&D and clinical services to biopharma and med‑tech sponsors. Core tracks span preclinical discovery and toxicology, clinical trial operations (Phases I–IV), site management/SMO, data management and biostatistics, central labs and imaging, regulatory/medical writing and pharmacovigilance, eClinical platforms, and real‑world evidence.The sector's total market cap is 130.48 billion USD, with a 24h change of +0.02%. Among 5 constituents, 2 are up (40.00%) and 3 are down (60.00%). The top gainer is Quest Diagnostics Inc. (DGX), with a 24h increase of +0.98%.CROs were flat with mixed breadth; quality leadership held. Near term, focus on leading names on dips; medium term, align positions with earnings and rate trends.
Name
Last Price
Change %
Last Price / Change %
Chart
Price Range
Action
IQV
IQVIQVIA Holdings Inc.
⁦$264.87⁩⁦$264.73⁩
-0.09%
-0.05%
AH
⁦$264.87⁩
-0.09%
⁦$261.36⁩⁦$265.35⁩
CRL
CRLCharles River Laboratories International, Inc.
⁦$335.63⁩⁦$330.00⁩
-0.74%
-1.67%
AH
⁦$335.63⁩
-0.74%
⁦$332.39⁩⁦$337.67⁩
DGX
DGXQuest Diagnostics Inc.
⁦$262.32⁩⁦$262.21⁩
+0.98%
-0.04%
AH
⁦$262.32⁩
+0.98%
⁦$261.03⁩⁦$262.32⁩
LH
LHLabcorp Holdings Inc.
⁦$372.44⁩⁦$372.46⁩
+0.48%
0.00%
AH
⁦$372.44⁩
+0.48%
⁦$369.88⁩⁦$372.44⁩
ICLR
ICLRIcon Plc
⁦$191.29⁩⁦$191.40⁩
-1.68%
+0.05%
AH
⁦$191.29⁩
-1.68%
⁦$189.00⁩⁦$192.11⁩